Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCLA.L Regulatory News (GCLA)

  • There is currently no data for GCLA

Stabilisation Notice

19 Oct 2007 11:15

Credit Suisse Securities (Eur) Ltd19 October 2007 PRE-STABILISATION ANNOUNCEMENT Not for distribution, directly or indirectly, in or into the United States orany jurisdiction in which such distribution would be unlawful. Grupo Clarin 19th October 2007 Pre-Stabilisation Notice Pursuant to Core Dealing Rule 3060-3061, Credit Suisse Securities (Europe)Limited hereby notifies the London Stock Exchange that it and its affiliates maystabilise the offering of the Security below Credit Suisse Securities (Europe) Limited, hereby gives notice that theStabilising Manager(s) named below may stabilise the offer of the followingsecurities in accordance with Commission Regulation (EC) No. 2273/2003implementing the Market Abuse Directive (2003/6/EC). The securities: Issuer: Grupo Clarin ISIN US40052A2096 REGs US40052A1007 144aGuarantor (if any): Aggregate nominal amount 19,250,000(Offering): Description: GDR Ratio 1 GDR : 2 B Share Offer price: USD 18.50 Other offer terms: Stabilisation: Stabilising Manager(s): Credit Suisse Securities (Europe) Limited Contact Felipe Portillo 44 20 7888 6522 Stabilisation period expected 19th October 2007 at approximately 12.00pm London time;to start on: Stabilisation period expected 16th November 2007 (30 days after the proposed issue date of theto end no later than: securities) Over-allotment option 15 % of the Offering Existence, maximum size and The Stabilising Manager(s) may over-allot the securities conditions of use of to the extent permitted in accordance with applicable law. over-allotment facility: In connection with the offer of the above securities, the Stabilising Manager(s)may over-allot the securities or effect transactions with a view to supportingthe market price of the securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun,may be ended at any time. Any stabilisation action or over-allotment shall beconducted in accordance with all applicable laws and rules. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of the Issuer in any jurisdiction. This material was produced by Credit Suisse Securities (Europe) Limited, a firmregulated and authorised by The Financial Services Authority (the "FSA"). Thisannouncement and the offer of the securities to which it relates are onlyaddressed to and directed at persons outside the United Kingdom and persons inthe United Kingdom who have professional experience in matters related toinvestments or who are high net worth persons within article 12(5) of theFinancial Services and Markets Act 2000 (Financial Promotion) Order 2005 andmust not be acted on or relied on by other persons in the United Kingdom. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the "Prospectus Directive") beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and theoffer are only addressed to and directed at persons in that Member State who arequalified investors within the meaning of the Prospectus Directive (or who areother persons to whom the offer may lawfully be addressed) and must not be actedon or relied on by other persons in that Member State. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the UnitedStates Securities Act of 1933 and may not be offered or sold in the UnitedStates absent registration or an exemption from registration. There will be nopublic offer of securities in the United States. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Nov 20237:00 amRNSGrupo Clarín Delisting of Global Depositary Shares
23rd Nov 20237:00 amRNSExpected Delisting of Global Depositary Shares
13th Nov 20237:00 amRNS3rd Quarter and 9 Month Results
25th Oct 20233:24 pmRNSBuy out of minority shareholders in subsidiary
9th Oct 202312:57 pmRNSFormer employee files claim
9th Oct 202312:56 pmRNSCompany makes equity contribution
7th Sep 20235:35 pmRNSConsumer association files claim
14th Aug 20237:53 amRNSHalf-year Report
14th Jun 20234:06 pmRNSLeave of Absence
9th Jun 20238:57 amRNSLeave of Absence
15th May 20237:00 amRNS1st Quarter Results
2nd May 20237:04 amRNSAnnual Financial Report
2nd May 20237:00 amRNSAudit Committee
28th Apr 20236:25 pmRNSDirectorate Change
28th Apr 20236:19 pmRNSGCSA Holds Shareholders' Meeting
14th Apr 20237:00 amRNSResponse to Shareholder Information Request
12th Apr 20237:00 amRNSResponse to Shareholder Information Request
22nd Mar 20234:54 pmRNSReplacement: Annual Shareholders’ Meeting
21st Mar 20237:25 amRNSAnnual Shareholders’ Meeting
14th Mar 202311:20 amRNSCorrection: Leave of Absence
14th Mar 20237:00 amRNSLeave of Absence
13th Mar 20237:00 amRNSFull Year and Last Quarter 2022 Results
6th Mar 20237:00 amRNSWebcast to discuss 4Q and FY 2022 results
15th Feb 20239:19 amRNSMinority shareholder files claim
16th Jan 20236:15 pmRNSSecretary of Trade imposes Fine on Subsidiary
28th Dec 20227:00 amRNSDirectorate Change
28th Dec 20227:00 amRNSResult of Meeting
28th Dec 20227:00 amRNSResult of Meeting
7th Dec 20229:00 amRNSResult of Meeting
7th Dec 20229:00 amRNSLeave of Absence
2nd Dec 20221:42 pmRNSDirectorate Change
14th Nov 20227:25 amRNSNine months and Third Quarter 2022 Results
31st Oct 20228:07 amRNSNotice of Results
27th Oct 20227:00 amRNSNotice to Global Depository Receipt Holders
9th Sep 20226:20 pmRNSAGM Statement
6th Sep 20221:07 pmRNSAcquisition
26th Aug 20227:00 amRNSLeave of Absence
23rd Aug 20227:00 amRNSResponse to Shareholder Information Request
12th Aug 20227:00 amRNSFirst Half and Second Quarter 2022 Results
3rd Aug 20226:22 pmRNSGCLA Calls Extraordinary Shareholders’ Meeting
25th Jul 20226:18 pmRNSNotice of Results
14th Jul 20221:11 pmRNSGuarantee in favour of Tele Red Imagen S.A
6th Jul 20229:07 amRNSCourt of Appeals Nullifies Resolution
17th Jun 20227:00 amRNSResponse to Shareholder Information Request
16th Jun 20224:20 pmRNSAppellate Decision in Pol-Ka Dispute
12th May 20227:00 amRNS1st Quarter 2022 Results
3rd May 20227:00 amRNSWebcast presentation to discuss 1Q 2022 results
20th Apr 20228:46 amRNSMembership of Audit Committee
19th Apr 20227:00 amRNSDirectorate Change
19th Apr 20227:00 amRNSGrupo Clarin holds Shareholders' Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.